- Motley Fool•2 months ago
Wall Street has high expectations in the coming year for Corcept Therapeutics, Incyte, and Exelixis.
- Zacks•3 months ago
Corcept Therapeutics (CORT) announced encouraging efficacy data from a phase I/II study on Korlym in patients with metastatic triple-negative breast cancer.
- Insider Monkey•3 months ago
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the unlimited research abilities of the big players […]
HTD.F : Summary for CORCEPT THERAPEUTICS INC. - Yahoo Finance
Corcept Therapeutics Incorporated (HTD.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 8:05AM CET. Market open.
|Bid||8.65 x 63700|
|Ask||8.82 x 61200|
|Day's Range||8.21 - 8.21|
|52 Week Range||3.61 - 9.23|
|PE Ratio (TTM)||210.54|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|